GlucoTrack, Inc..
GCTK.US | Manufacture of medical and dental instruments and supplies
GlucoTrack, Inc. is a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes. Their primary product, GlucoTrack, is a non-invasive device designed to provide pain-free glucose monitoring for individuals with Type 2 diabetes and...Show More
Better Health for All
0
No evidence available to assess GlucoTrack, Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
No evidence available to assess GlucoTrack, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
-50
As of December 31, 2024, none of the company's eleven full-time employees were represented by a collective bargaining agreement.
1
For worker engagement, the company has a Glassdoor rating of 5.0/5 based on a single review,
2
and employees rate overall compensation and benefits 4/5 stars. The Glassdoor rating of 5.0/5 from one review is not sufficient to score the worker engagement KPI, as it lacks a broader, representative engagement score. However, the 4/5 stars for compensation and benefits is a specific employee rating,
3
which translates to 80% satisfaction. This falls into the -60 tier for worker engagement, as it is below the 40/100 threshold for positive engagement.
Fair Trade & Ethical Sourcing
0
The provided articles do not contain specific, concrete data points for GlucoTrack, Inc. regarding fair trade certification share, audit frequency, forced or child labor incidents, traceability coverage, remediation speed, ethical clause coverage, materials risk index, or supplier diversity spend.
Honest & Fair Business
0
No evidence available to assess GlucoTrack, Inc. on Honest & Fair Business.
Kind to Animals
-40
GlucoTrack, Inc. conducts preclinical animal testing for its implantable continuous glucose monitor, with studies involving ovine (sheep) and swine models.
1
One study used 11 animals, and another used 2 adult male sheep.
2
The company has not provided any public data on its overall animal welfare policies or practices, indicating an absence of a formal policy.
3
There is no information available regarding cruelty-free certifications, alternative testing methods, humane certifications, wildlife conservation initiatives, ethical input substitutions, supplier audits, cage-free sourcing, or animal agriculture ethics.
4
No War, No Weapons
0
No evidence available to assess GlucoTrack, Inc. on No War, No Weapons.
Planet-Friendly Business
-10
GlucoTrack has a waste recycling rate of 68%.
1
Respect for Cultures & Communities
0
No evidence available to assess GlucoTrack, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
-20
The company has reported no previous cybersecurity incidents materially affecting it.
1
It obtained ISO 13485:2016 certification from BSI.
2
The company implements two-factor authentication for logins.
3
It conducts annual risk assessments and quarterly vulnerability scans.
4
The company mentions compliance with FDA regulations, ISO 13485, and HIPAA standards for some business partners.
5
Zero Waste & Sustainable Products
-20
GlucoTrack's implantable CBGM design significantly reduces single-use plastic, replacing approximately 73 disposable sensors with one piece of electronic waste over 36 months, which represents a 98.6% reduction in items.
1
The device is designed for continuous use for up to 3 years, exceeding typical industry lifespans.
2
The core design of the implantable CBGM is a waste reduction initiative, focusing on long-term use and minimizing disposables, aligning with circular economy principles. However, the company does not explicitly state waste reduction targets beyond the inherent design benefits. While the FDA focuses on proper disposal of hazardous materials like heavy metals and batteries in electronic devices for 2025,
3
there is no specific evidence of GlucoTrack's hazardous waste management practices or minimization efforts, only a general compliance approach. The company has no reported waste disposal violations in the past three years. The material input per unit and packaging-to-product ratio are implied to be reduced compared to traditional CGMs, but no specific quantitative data is provided to compare against industry averages.